Integrin alpha 5 beta 1 Protein, Human (Biotinylated, HEK293, His-Avi)

ITGA5, a versatile receptor, interacts with diverse ligands such as fibronectin, fibrinogen, PLA2G2A, fibrillin-1 (FBN1), IL1B, Human metapneumovirus, and soluble CD40LG. Recognizing the R-G-D sequence, ITGA5 mediates cell adhesion through distinct binding sites. Notably, it binds PLA2G2A at a separate site, inducing conformational changes enhancing ligand binding. ITGA5's role in IL1B signaling, microbial infection, and CD40/CD40LG signaling highlights its multifunctionality in cellular processes and signaling pathways. Integrin alpha 5 beta 1 Protein, Human (Biotinylated, HEK293, His-Avi) is a recombinant protein dimer complex containing human-derived Integrin alpha 5 beta 1 protein, expressed by HEK293, with C-Avi, C-His labeled tag. Integrin alpha 5 beta 1 Protein, Human (Biotinylated, HEK293, His-Avi), has molecular weight of 110-140 kDa.

The Integrin alpha-5/beta-1 protein (ITGA5:ITGB1) functions as a versatile receptor with diverse ligand interactions. Recognizing the R-G-D sequence in its ligands, ITGA5:ITGB1 serves as a receptor for fibronectin and fibrinogen, mediating cell adhesion through distinct binding sites. Notably, it binds to PLA2G2A at a site separate from its classical ligand-binding site, inducing conformational changes that enhance ligand binding. Additionally, ITGA5:ITGB1 acts as a receptor for fibrillin-1 (FBN1), facilitating R-G-D-dependent cell adhesion. It is also a receptor for fibronectin (FN1), enabling R-G-D-dependent cell adhesion to FN1. Furthermore, ITGA5:ITGB1 serves as a receptor for IL1B, playing a crucial role in IL1B signaling. In the context of microbial infection, ITGA5:ITGB1 acts as a receptor for Human metapneumovirus, highlighting its involvement in pathogen recognition. Moreover, ITGA5:ITGB3 acts as a receptor for soluble CD40LG, playing a vital role in CD40/CD40LG signaling. This broad spectrum of ligand interactions underscores the multifunctionality of ITGA5:ITGB1 in cellular processes and signaling pathways.

Human

HEK293

C-Avi;C-His

P08648 (F42-Y995)&P05556 (Q21-D728)

3678&3688

110-140 kDa

Greater than 95% as determined by reducing SDS-PAGE.

<1 EU/μg, determined by LAL method.